No one makes the right decisions every time or even every year. Not even the best of the fund managers like Bill Miller, the brilliant manager of Legg Mason Value Trust, who outperformed the S&P for 15 straight years, but lagged well behind last year. Even Warren Buffett, probably the smartest investor of our time, could have pocketed billions by selling Coca-Cola when it was in the 80s and instead rode it down to the 40s.
After 35 years of making good and bad decisions, setting goals and then abandoning them, buying good-quality stocks but also chasing performance, almost giving up after two grinding bear markets at the end of the road I��e realized that the best investment advise will at best be boring .
Lesson 1: Diversify. Buying just a few shares of four stocks cost more in commissions than had I put all my money in one stock. But had I bought just one, it might well have been the wrong one. As it turned out, five years later, one of those stocks had gained just 9% while another one had nearly doubled.
Top 10 Warren Buffett Companies To Buy For 2014: Wind River Energy Corp (WVR.V)
Wind River Energy Corp. engages in the acquisition and development of oil and gas properties in the Rocky Mountain and mid-continent regions of the United States. It owns interest in the Phat City Project in Montana, Day Butte and Meadow Draw Projects in Wyoming, the Milagro Project in New Mexico and Colorado, the Emerald Forest Project in Wyoming, and the Kansas Project in Kansas. The company is based in Vancouver, Canada.
Top 10 Warren Buffett Companies To Buy For 2014: Nice Systems Ltd (NICE)
NICE-Systems Ltd. (NICE), incorporated on September 28, 1986, is a provider of solutions that enable enterprises and security organizations to extract insight from interactions, transactions and surveillance to drive business performance and ensure safety and security. Its solutions enable companies and public organizations to capture, manage, analyze and impact unstructured interaction, as well as transactional data, enabling such entities to comply with internal and governmental regulations, improve business and operational performance and address security threats while increasing situational awareness. Unstructured content includes cross-channel analysis of phone calls, chat, instant messaging and e-mail interactions to contact centers, trading floors, branches, home agents and back offices, phone calls to emergency service providers and first responders, video captured by closed circuit cameras, radio communications between emergency services��and first responders��personnel, Internet sessions, e-mail and instant messaging and security management solutions for command and control centers. In May 2010, the Company acquired Lamda Communication Networks Ltd.
On January 11, 2010, NICE completed the acquisition of certain assets and liabilities of Orsus Solutions Limited and certain subsidiaries of Orsus. On August 31, 2009, NICE and certain subsidiaries of NICE completed the acquisition of the voting securities of certain subsidiaries of Fortent, Inc. (Fortent). On August 31, 2009, NICE completed the acquisition of Hexagon System Engineering Ltd. (Hexagon). On June 17, 2009, the Company completed the acquisition of Syfact.
The Company�� products include NICE SmartCenter, NICE Perform Interaction Recording, NICE Perform eXpress (NPX), NICE Quality Management, NICE Interaction Analytics, NICE Real-Time Guidance, NICE Packaged Business Solutions, NICE Feedback, NICE IEX Workforce Management, Performance Manager, Network Embedded Logger and NiceCall Focus III. It also incl! udes Actimize Fraud Prevention Suite, Actimize Anti-Money Laundering Suite, Actimize Brokerage Compliance Suite, Actimize Enterprise Risk Case Manager, Mirra IV, NICE Inform, NiceVision Net, NiceVision ControlCenter, NiceVision Analytics, NiceVision Digital, NiceVision SafeRoute, NICE Situator, FAST alpha Silver, NiceTrack.
NICE SmartCenter leverages the synergies of the combined capabilities of NICE Perform, NICE Quality Management, NICE Interaction Analytics, NICE Feedback, IEX TotalView and Performance Manager. NICE Perform Interaction Recording records customer interactions with contact center agents, financial trading floors, investment banking and enterprises, with a separate suite of applications for contact centers and investment banking, including for organizations that have a relatively small number of input channels. NICE Perform eXpress (NPX) brings the capabilities of Nice Perform into a single box, low TCO solution based on commercial hardware for small businesses or small systems. NICE Quality Management delivers tools for implementing a multifaceted quality program encompassing agents, supervisors, evaluators and managers.
NICE Interaction Analytics utilizes a multi-dimensional analysis approach to analyze customer interactions across communication channels and provide automated business insight and root cause analysis based on speech analytics, e-mail and chat analysis, call flow analysis, screen content analysis and integration with customer relationship management (CRM) data. NICE Real-Time Guidance leverages interaction analytics in order to provide recommendations to the agent in real-time during a phone or chat interaction with a customer, popping up contextually relevant instructions to the agent within call-out windows.
NICE Packaged Business Solutions is a set of out-of-the-box solutions designed to address common contact center challenges, including Customer Churn Reduction, Sales Effectiveness, Customer Experience, Marketing Effective! ness, Col! lections Optimization, Quality Optimization, such as First Contact Resolution and Average Handling Time. NICE Feedback is a solution for collecting real-time customer feedback after a call or any other type of interaction with the organization. NICE IEX Workforce Management forecasts customer interactions, schedules agents with appropriate skills to manage and optimize level of customer service and resources, measures agent and team performance and supports managing overall contact center performance
Performance Manager maps enterprise business objectives to group and individual goals, tracks and reports performance. Network Embedded Logger offers a Linux based voice over Internet protocol (VoIP) Logger embedded in Cisco routers, suitable for branch recording with NICE Perform. NiceCall Focus III provides a voice recording system for organizations that have a relatively small number of input channels and a cost-effective solution for branch recording (TDM only) with centralized storage. Actimize Fraud Prevention Suite is a suite of focused cross-channel fraud prevention solutions, available individually or as an integrated whole, used in both real-time and batch processing to detect and prevent the fraud.
Actimize Anti-Money Laundering Suite is an end-to-end suite of solutions that are available individually or as an integrated whole used to monitor and identify suspicious activities for customers and facilitate regulatory compliance processes. Actimize Enterprise Risk Case Manager is a centralized platform for holistic case and alert management that enables an enterprise-wide approach to risk and compliance operations management. Mirra IV provides small recording system that is suited to simple recording applications, in which it can record up to 48 channels of voice traffic from a variety of analog and digital interfaces. NICE Inform provides information management solution for management of multimedia interactions for security command and control centers, enables effectiv! e managem! ent of multimedia incident information from various sources, for faster incident reconstruction, greater insight and improved response.
NiceVision Net provides a complete solution for Internet protocol (IP) video security, including encoders, decoders and network video recorders. NiceVision ControlCenter provides a control room management and network-based digital video matrix. NiceVision Analytics provides a set of video content analytics applications for automated detection of threats, safety and operational related events. NiceVision Digital provides a portfolio of digital video recorders for different capacities and performance requirements. NiceVision SafeRoute provides a solution for mobile video surveillance onboard public transport vehicles. FAST alpha Silver provides digital video monitoring and recording solution for large to mid-size applications. NiceTrack provides interception, delivery, monitoring, collection and advanced analysis of telecommunication interactions.
The Company competes with Aspect Software, Inc., Autonomy Corp., Cybertech International, eLoyalty, Genesys Telecommunicatons, Nexidia, Verint Systems Inc., ACI Worldwide, FICO, Mantas, Inc., Norkom Group plc, Oracle Corporation, SAS Institute Inc., Sungard Data Systems Inc., ASC Telecom, AudioSoft, Redbox Recorders, Bosch, Genetec Inc., IndigoVision, Milestone Systems A/S, ONSSI, Schneider Electric, Atis, ETI, JSI Telecom, Pen-link Ltd., SS8 Networks, Inc. and Trovicor.
Advisors' Opinion:- [By Roberto Pedone]
Nice Systems (NICE) provides software solutions that deliver insights by capturing and analyzing mass quantities of structured and unstructured data in real time from multiple sources such as interactions, transactions and surveillance. This stock closed up 2.1% to $38 in Wednesday's trading session.
Wednesday's Volume: 430,000
Three-Month Average Volume: 135,436
Volume % Change: 218%From a technical perspective, NICE trended modestly higher here back above its 50-day moving average of $37.69 with heavy upside volume. This move is quickly pushing shares of NICE within range of triggering a big breakout trade. That trade will hit if NICE manages to take out some near-term overhead resistance at $38.90 to its three-year high at $39.89 with high volume.
Traders should now look for long-biased trades in NICE as long as it's trending above its 50-day at $37.69 or above Wednesday's low of $36.91, and then once it sustains a move or close above those breakout levels with volume that hits near or above 135,436 shares. If that breakout hits soon, then NICE will set up to enter new three-year high territory, which is bullish technical price action. Some possible upside targets off that move are $43 to $45.
Top 5 Oil Stocks To Own For 2014: Crown Media Holdings Inc.(CRWN)
Crown Media Holdings, Inc., through its subsidiary, Crown Media United States, LLC, owns, operates, and distributes pay television networks for adults and families primarily in the United States. The company operates and distributes Hallmark Channel network to approximately 87 million subscribers through approximately 5,369 cable, satellite, and other pay television distribution systems; and Hallmark Movie Channel network to approximately 45 million subscribers through approximately 2,680 cable, satellite, and other pay television distribution systems. Its networks offers a range of entertainment programming, including television series, movies, miniseries, theatricals, romances, literary classics, and contemporary stories. The company was founded in 1999 and is headquartered in Studio City, California.
Top 10 Warren Buffett Companies To Buy For 2014: Cascade Microtech Inc.(CSCD)
Cascade Microtech, Inc. designs, develops, manufactures, and markets wafer probing and test socket solutions for the electrical measurement and testing of high performance chips. It offers a range of product lines, including probe stations, analytical probes, production probe cards, test sockets, and various services. The engineering probe station is used in conjunction with analytical probes to test chips in wafer form for forming a probing system; and analytical probes, production probe cards, and test sockets electrically connect test equipment to the chips under test and are sold as consumable test tooling, which are mounted into production or engineering probe stations. The company also offers Pyramid Probe card product line for use in wireless chip applications, as well as probe station accessories, including thermal control systems, microscopes, lasers, cameras, special cables, and connectors and other items. In addition, it provides installation and maintenance ser vices. The company sells its products to semiconductor manufacturers, test subcontractors, research organizations, and designers through a combination of manufacturers? representatives, distributors, and direct sales people primarily in the United States, the Asia Pacific, and Europe. Cascade Microtech, Inc. was founded in 1983 and is headquartered in Beaverton, Oregon.
Top 10 Warren Buffett Companies To Buy For 2014: (SUZLON.NS)
Suzlon Energy Limited engages in the design, development, manufacture, and supply of wind turbine generators in the Americas, Asia, Australia, and Europe. The company?s product portfolio includes drive systems, annular generators, and grid connection systems, as well as towers and foundations comprising tower constructions, tubular steel towers, precast concrete towers, and foundation constructions. It also involves in the sale/sub-lease of land; infrastructure development; sale of gear boxes, and foundry and forging components; and power generation operations. In addition, the company offers land sourcing and permitting, wind resource assessment, and erection and commissioning services, as well as operations and maintenance services for projects. Suzlon Energy Limited was founded in 1995 and is based in Pune, India.
Top 10 Warren Buffett Companies To Buy For 2014: Sarepta Therapeutics Inc (SRPT)
Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., incorporated on July 22, 1980, biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases. The Company�� product candidates include Eteplirsen, AVI-6002, AVI-6003, and AVI-7100. As of December 31, 2011, the Company primarily focused on advancing the development of its Duchenne muscular dystrophy drug candidates, including its lead product candidate, eteplirsen, which is in a Phase IIb trial. The Company is also focused on developing therapeutics for the treatment of infectious diseases, including its lead infectious disease programs aimed at the development of drug candidates for the Ebola and Marburg hemorrhagic fever viruses. The Company's program focuses on the development of disease-modifying therapeutic candidates for Duchenne muscular dystrophy (DMD). The Company initiated a Phase IIb trial for eteplirsen in August 2011 with an objective of initiating a pivotal trial subsequent to 2011.
The Company is also leveraging the capabilities of its RNA-based technology platforms to develop therapeutics for the treatment of infectious diseases. The Company's RNA-based drug programs are clinically evaluated for the treatment of DMD and have also demonstrated anti-viral activity in infectious diseases such as Ebola, Marburg and H1N1 influenza in certain animal models. The Company's lead product candidates are at various stages of development.
Duchenne Muscular Dystrophy Program
The Company's lead program is designed to address specific gene mutations that result in DMD by forcing the genetic machinery to skip over an adjacent contiguous piece of RNA and, thus, restore the ability of the cell to express a new, truncated but functional, dystrophin protein.
Eteplirsen is an antisense PMO-based therapeutic in clinical development for the treatment of individuals with DMD who have an error in the gene codi! ng for dystrophin that can be treated by skipping exon 51. Eteplirsen targets the frequent series of mutations that cause DMD. Eteplirsen has been granted orphan drug designation in the United States and European Union. In addition to the Company's lead product candidate, eteplirsen, the Company is actively pursues development of a product candidate that skips exon 45 through an IND-enabling collaboration.
Anti-Viral Programs
The Company is implementing its RNA-based technology platforms in its anti-viral programs for the development of therapeutics to treat viruses, such as Ebola, Marburg and influenza. The Company's arrangement with DoD supporting the development of the Company's Ebola and Marburg virus drug candidates provides funding for all clinical and licensure activities necessary to obtain approval of a New Drug Application (NDA), by the United States Food and Drug Administration (FDA), if DoD exercises all of its options under the arrangement. During the year ended December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and is exploring funding opportunities or partnerships with DHHS and industry collaborators to advance its development.
The Company's anti-viral therapeutic programs use the Company's translation suppression technology and applies its PMOplus chemistry backbone, an advanced generation of its base PMO chemistry backbone that selectively introduces positive backbone charges to improve selective interaction between the drug and its target. The Company's translation suppressing technology is based on Translation Suppressing Oligomers (TSOs), which are PMO-based compounds that stop or suppress the translation of a specific protein by binding to their specific target sequence in mRNA.
The Company is pursuing development and regulatory approval of its Ebola and Marburg hemorrhagic fever virus product candidates under the FDA's Animal Rule. The Company's lead product candidate against the Ebola virus infec! tion is A! VI-6002. For Marburg virus infection, the Company's lead product candidate has been AVI-6003. In February 2012, the Company announced that the Company received approval from the FDA to remove one of the two oligomers composing AVI-6003 and proceed with a single oligomer approach, AVI-7288, given that efficacy in non-human primates has been demonstrated to be attributable to this single oligomer. The Company is exploring the feasibility of alternate routes of administration of its Ebola and Marburg drug candidates, and at DoD's invitation, the Company is developing a proposal to be submitted for a study to demonstrates feasibility of the intramuscular route.
AVI-6002, which is a combination of AVI-7537 and AVI-7539, is designed for post-exposure prophylaxis after documented or suspected exposure to the Ebola virus. The Company is evaluating the feasibility of developing AVI-7537 as a single agent for the post-exposure prophylaxis after documented or suspected exposure to Ebola virus. AVI-6003, which is a combination of AVI-7287 and AVI-7288, is designed for post-exposure prophylaxis after documented or suspected exposure to Marburg virus. In February 2012, the Company announced that the Company received approval from the FDA to proceed with AVI-7288 as a single agent against Marburg virus infection. The Company intends to proceed with dosing AVI-7288 in the Phase I multiple ascending dose studies and in non-human primate studies.
Influenza Program
The Company's anti-viral therapeutic programs are also focused on the development of the Company's product candidates designed to treat pandemic influenza viruses. AVI-7100 is the Company's lead product candidate for the treatment of influenza and employs its PMOplus technology. In June 2011, the Company initiated dosing of AVI-7100 through intravenous infusion in single-ascending doses in up to 48 healthy adult volunteers. As of December 31, 2011, the Company paused its clinical development efforts on AVI-7100 and are exp! loring fu! nding opportunities or partnerships to advance its development.
The Company has developed three new phosphorodiamidate-linked morpholino oligomers (PMO)-based chemistry platforms in addition to its original PMO-based technology. The Company's PMO-based molecules are designed to sterically block the access of cellular machinery to pre-mRNA and mRNA without degrading the RNA. Through this selective targeting, two distinct biologic mechanisms of action can be initiated: modulation of pre-mRNA splicing and inhibition of mRNA translation.
The Company competes with GlaxoSmithKline plc, Toyama Chemical, Alnylam Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., Isis Pharmaceuticals, Inc., Prosensa, and Santaris Pharma A/S.
Advisors' Opinion:- [By Teresa Rivas]
Sarepta Therapeutics (SRPT) and Prosensa Holding NV (RNA) were both big movers today, although in very different directions.
At recent check, Prosensa was down 69%. Earlier today the company, partnered with GlaxoSmithKline (GSK), announced that the primary endpoint in its Phase 3 study of its Duchenne muscular dystrophy treatment Drisapersen was not met.
In a randomized double-blind study of 186 boys over 48 weeks, the drug did not show statistically significant improvement in the 6 Minute Walking Distance (6MWD) test compared to a placebo.
On a conference call, management said that it could take weeks, if not months to analyze the data, and thus could not offer guidance in regard to its next step would be.
By contrast Sarepta was jumping 22% on the news, as it is developing the drug Eteplirsen as a rival treatment. Barron�� Andrew Bary correctly predicted last month that Prosensa�� loss would be Sarepta�� gain. Nonetheless, there was some chatter about potentially increased difficulty for Eteplirsen�� approval in the wake of the Drisapersen disappointment.
Still, both Needham’s Chad Messer and Robert W. Baird’s Brian Skorney view the news as a bullish event.
Messer writes “Although we concede some people, potentially including the FDA, may now be more skeptical of exon-skipping technology in general, we are confident in Etelpirsen’s efficacy based on the long-term consistency of the Phase IIb data.” He also believes that with Drisapersen’s removal, there is less risk to Etelpirsen’s market share position. He has a $57 price target on the stock.
Skorney also notes that the news may not be all positive, given the possibility of caution from regulators, but writes “we believe the elimination of Prosensa as a potential competitor more than offsets any increase in risk to the fundamental thesis.” He has a $63 price target on the stock.
Top 10 Warren Buffett Companies To Buy For 2014: Generac Holdlings Inc. (GNRC)
Generac Holdings Inc. designs, manufactures, and markets a range of generators and other engine powered products for the residential, light commercial, industrial, and construction markets in the United States and Canada. It offers generators and other products fueled by natural gas, liquid propane, gasoline, diesel, and Bi-Fuel under the Generac and Magnum brands. The company�s product line includes residential power products, commercial and industrial power products, and other products. Its residential power products comprise automatic residential standby generators that range in output from 6kW to 60kW; air-cooled residential standby generators, which range in outputs from 6kW to 20kW; and liquid-cooled generators that range in outputs from 20kW to 60kW. The residential power product line also includes portable generators consisting of GP series ranging from 1,850W to 17,500W for homeowners; the XG series ranging from 4,000W to 10,000W for the premium homeowner market; the XP series ranging from 4,000W to 8,000W for the professional contractor market; and the iX series ranging from 800W to 2,000W for the recreational market. The company�s industrial and commercial power products comprise light-commercial standby generators ranging from 22kW to 150kW for grocery stores, convenience stores, restaurants, gas stations, pharmacies, retail banks, and healthcare facilities; single-engine industrial generators, which range in output from 10kW to 600kW; and generator systems ranging from 20kW air-cooled generators to 3mW modular power system for the telecommunications market, as well as aftermarket service parts and RV generators. The company sells its generators through independent residential and industrial dealers, wholesalers, national accounts, private label arrangements, retailers, catalogs, e-commerce merchants, equipment rental companies and dealers, and construction companies. Generac Holdings Inc. was founded in 1959 and is headquartere d in Waukesha, Wisconsin.
Advisors' Opinion:- [By Rich Duprey]
Generator maker Generac (NYSE: GNRC ) announced this morning it had completed the refinancing of its senior secured�term loan credit facility and, as it previously promised, will use part of the proceeds to pay investors a special dividend of $5.00 per share,�payable on June 21�to stockholders of record on June 12.�
Top 10 Warren Buffett Companies To Buy For 2014: Agilent Technologies Inc (A&)
Agilent Technologies, Inc. (Agilent), incorporated on May 5, 1999, is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2011 (fiscal 2011), it had three business segments: electronic measurement business, chemical analysis business and life sciences business. Its electronic measurement business addresses the communications, electronics and other industries. Agilent�� chemical analysis business focuses on the petrochemical, environmental, forensics and food safety industries. Its life sciences business focuses on the pharmaceutical, biotechnology, academic and Government, bio-agriculture and food safety industries. In addition to its three businesses, it conducts research through Agilent Technologies Laboratories (Agilent Labs). In fiscal 2011, the Company acquired A2 Technologies, Lab901 and Biocius Life Sciences Inc. On December 21, 2011, the Company acquired BioSystem Development business and P.V.R. s.r.l., a vacuum pump manufacturer. In February 2012, the Company acquired software solutions and technology for device-level modeling and validation from Accelicon Technologies. In June 2012, the Company acquired cancer diagnostics company, Dako. In August 2012, the Company acquired Aurora SFC Systems, Inc.
Electronic Measurement Business
The Company�� electronic measurement business provides electronic measurement instruments and systems, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. It also offers customization, consulting and optimization services throughout the customer's product lifecycle. It sells products and services applicable to a rang! e of communications networks and systems, including wireless communications and microwave networks, voice, broadband, data, and fiber optic networks. Test products include Electronic Design Automation (EDA) software, vector and signal analyzers, signal generators, vector network analyzers, one box testers, oscilloscopes, logic and protocol analyzers, and bit-error ratio testers.
The Company�� wireless communications and microwave network products include radio frequency and microwave test instruments and electronic design automation software tools. These products are required for the design and production of wireless network products, communications links, cellular handsets and base stations. It provides handheld products for the installation and maintenance of wireless networks. Its electronic design automation software tools and instruments are used by radio frequency integrated circuit design engineers to model, simulate and analyze communications product designs at the circuit and system levels.
The Company�� suite of fiber optic test products measure and analyze a range of optical and electrical parameters in fiber optic networks and their components. Components which can be tested with Agilent solutions include source lasers, optical amplifiers, filters and other passive components. Test products include optical component analyzers, optical power meters and optical spectrum analyzers. It sells the products into the general purpose test market, including general purpose instruments, modular instruments and test software, digital test products, semiconductor and board test solutions, electronics manufacturing test equipment, atomic force microscopes and radio frequency and network surveillance solutions. The Company�� general purpose products include spectrum analyzers, network analyzers, signal generators, logic analyzers, digitizing oscilloscopes, voltmeters, multimeters, frequency counters, bench and system power supplies, function generators and waveform synthesizers. Modular! instrume! nts and test software are used by the designers and manufacturers of electronic devices as the building blocks of systems that can be configured for a range of test applications.
The Company�� digital test products are used by research and development engineers across a range of industries to validate the function and performance of their digital product and system designs. These designs include a range of products from digital control circuits to high speed systems, such as computer servers and the gaming consoles. The test products offered include oscilloscopes, logic and serial protocol analyzers, logic-signal sources and data generators.
The Company�� semiconductor and board test solutions enable customers to develop and test semiconductors, test and inspect printed circuit boards, perform functional testing, and measure position and distance information to the sub-nanometer level. It is a supplier of parametric test instruments and systems used to examine semiconductor wafers during the manufacturing process. Its in-circuit test system helps identify quality defects, such as faulty or incorrect parts, that affect electrical performance. Its laser interferometer measurement systems provide precise position or distance information for dimensional measurements. Its atomic force microscopes (AFM) are imaging devices. An AFM allows researchers to observe and manipulate molecular and atomic level features. Its portfolio of AFM products provides customers with tools for a range of nanotechnology applications, including semiconductor, data storage, polymers, materials science and life science studies. The Company�� surveillance systems and subsystems are used by defense and government engineers and technicians to detect, locate and analyze signals of interest. The products offered include receivers for detecting radio frequency signals, probes for detecting wire line signals and software that enables the identification and analysis of these signals. Agilent's electronic measureme! nt custom! ers include contract manufacturers of electronic products, handset manufacturers and network equipment manufacturers who design, develop, manufacture and install network equipment, service providers who implement, maintain and manage communication networks and services, and companies who design, develop, and manufacture semiconductors and semiconductor lithography systems. Its customers use its products to conduct research and development, manufacture, install and maintain radio frequency, microwave frequency, digital, semiconductor, and optical products and systems and conduct nanotechnology research.
The Company competes with Aeroflex Incorporated, Anritsu Corporation, Ansys Corporation, EXFO Electro-Optical Engineering, Inc., National Instruments Corporation, Rohde & Schwartz GmbH & Co. KG, Spirent plc, Danaher Corporation, Bruker Corporation, LeCroy Corporation, Teradyne, Inc., Test Research Inc. and Zygo Corporation.
Chemical Analysis Business
The Company�� chemical analysis business provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and chemical properties of substances and products. Its product categories in chemical analysis include gas chromatography (GC) systems, columns and components; gas chromatography mass spectrometry (GC-MS) systems; inductively coupled plasma mass spectrometry (ICP-MS) instruments; atomic absorption (AA) instruments; inductively coupled plasma optical emission spectrometry (ICP-OES) instruments; software and data systems; vacuum pumps and measurement technologies; services and support for its products. Agilent provides custom or standard analyzers configured for specific chemical analysis applications, such as detailed speciation of a complex hydrocarbon stream, calculation of gas calorific values in the field, or analysis of a new bio-fuel formulation. It also offers related software, accessories and consumable ! products ! for these and other similar instruments. Its MS products incorporate technologies for measuring mass, including single-quadrupole, triple-quadrupole, and ion trap mass spectrometers. It combines its mass spectrometers with other instruments to instruments, such as GC/MS, and ICP-MS. It also offers related software, accessories and consumable products for these and other similar instruments. The Company�� spectroscopy instruments include atomic absorption (AA) spectrometers, inductively coupled plasma-optical emissions spectrometers (ICP-OES), inductively coupled plasma-mass spectrometers (ICP-MS), fluorescence spectrophotometers, ultraviolet-visible (UV-Vis) spectrophotometers, Fourier Transform infrared (FT-IR) spectrophotometers, near-infrared (NIR) spectrophotometers, Raman spectrometers and sample automation products. It also offers related software, accessories and consumable products for these and other similar instruments.
The Company�� vacuum technologies products are used to create, control, measure and test vacuum environments in life science, industrial and scientific applications where clean and vacuum environments are needed. Products include a range of vacuum pumps, including diffusion, turbomolecular and ion getter; intermediate vacuum pumps, including rotary vane, sorption and dry scroll, vacuum instrumentation, including vacuum control instruments, sensor gauges and meters, and vacuum components, including valves, flanges and other mechanical hardware. Its products also include helium mass spectrometry and helium-sensing leak detection instruments used to identify and measure leaks in hermetic or vacuum environments. The Company offers a range of services, including an exchange and rebuild program, assistance with the design and integration of vacuum systems, applications support and training in basic and advanced vacuum technologies. The Company offers a range of consumable products, which support its technology platforms, including sample preparation consumables, suc! h as soli! d phase extraction (SPE) and filtration products, self manufactured GC and LC columns, chemical standards, and instrument replacement parts. Consumable products also include scientific instrument parts and supplies, such as filters and fittings for GC systems; xenon lamps and cuvettes for UV-Vis-NIR, fluorescence, FT-IR and Raman spectroscopy instruments; and graphite furnace tubes, hollow cathode lamps and specialized sample introduction glassware for its AA, ICP-OES and ICP-MS products.
The Company competes with Bruker Corporation, PerkinElmer Inc., Shimadzu Corporation and Thermo Fisher Scientific Inc.
Life Sciences Business
The Company�� life sciences business provides application-focused technologies and solutions, which include instruments, software, consumables and services. Its product categories include liquid chromatography, mass spectrometry, microarrays, polymerase chain reaction (PCR) instrumentation, bioreagents, electrophoresis, software and informatics, nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) systems, and, consumables and services. The Agilent liquid chromatograph (LC) portfolio is modular in construction and can be configured as analytical and preparative systems. Agilent's liquid chromatography/ mass spectrometer (LC/MS) portfolio includes instruments built around five analyzer types, such as single quadrupole, triple quadrupole, ion trap, time-of-flight (TOF) and quadrupole time-of-flight (QTOF). It is a provider of microarray-based, genomics research solutions. It provides products for sequencing platforms. Its portfolio of PCR instrumentation, reagents and kits, coupled with its other products, such as microarrays and target enrichment systems for sequencing, provides a range of workflow solutions to customers in the genomics marketplace.
Agilent is a supplier of electrophoretic separation solutions. The 2100 Bioanalyzer analyzes biomolecules or cells in microfluidic networks of channels and wells etched i! nto glass! chips. The 3100 OFFGEL Fractionator resolves proteins or peptides by isoelectric point with liquid-phase recovery. It provides software for instrument control, data acquisition, data analysis, laboratory content and business process management, and informatics. With OpenLab, Agilent has open architecture, which enables capture, analyze, and share scientific data throughout the lab and across the enterprise. It offers a range of consumable products, which support its LC, and MS technology platforms. These consumable products include sample preparation products; self manufactured LC columns and instrument replacement parts, and consumable supplies to meet its customers' analysis needs. It offers a range of startup, operational, educational and compliance support services for measurement and data handling systems. Its support services include maintenance, troubleshooting, repair and training for all of its chemical and bioinstrumentation analysis hardware and software products.
The Company competes with Affymetrix Inc., Bruker Corp., Danaher Corporation, Illumina, Inc., Life Technologies Corp., Thermo Fisher Scientific Inc. and Waters Corp.
Top 10 Warren Buffett Companies To Buy For 2014: Crown Ltd(CWN.AX)
Crown Limited operates in gaming and entertainment industry primarily in Australia. It owns and operates two integrated resorts, including Crown Entertainment Complex in Melbourne and Burswood Entertainment Complex in Perth. The company?s Crown Entertainment Complex comprises 2,500 electronic gaming machines and approval to operate 500 table games; three hotels offering approximately 1,600 rooms, including 31 luxury villas; conference centre; banqueting facilities; 70 restaurants and bars; boutiques and retail outlets; a multi-screen cinema complex; a bowling alley; and an interactive gaming auditorium. Its Burswood Entertainment Complex includes approval to operate 2,000 gaming machines and 220 table games; 2 hotels; 22 restaurants and bars; a nightclub; a convention centre; 2,300 seat Burswood theatre; 20,000 seat Burswood dome; a day spa; and retail outlets. The company also owns and operates the Aspinalls Club, a high end casino in London. In addition, Crown holds int erest in casino/hotel properties in Macau, which include the City of Dreams, Altira Macau, and Mocha Clubs; and owns a portfolio of gaming investments comprising an online betting exchange, four casinos in Nevada and Western Pennsylvania, and a casino business in the United Kingdom. The company is based in Southbank, Australia.
Top 10 Warren Buffett Companies To Buy For 2014: Fischer Tech Ltd (F22.SI)
Fischer Tech Ltd, together with its subsidiaries, manufactures and sells precision engineering plastic components for electronic products. It offers plastic components used in products for the automotives, smart phones, computer peripherals, healthcare, and consumer product industries, as well as is involved in laser marking and decorative finishing for engineering components. The company also designs and manufactures precision plastic injection moulds used in the manufacture of plastic injection components; and engages in the high precision injection molding. In addition, it manufactures in-mould labeling (IML) plastic key pads and IML plastic components. The company sells its products in north Asia and southeast Asia. Fischer Tech Ltd was founded in 1994 and is headquartered in Singapore.
No comments:
Post a Comment